EATG » Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis and TB drug prices, study shows

Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis and TB drug prices, study shows

HIV, hepatitis B and C and TB can each be treated for less than $90 a year where generic drugs can be made available, Dzintars Gotham of Imperial College, London, reported at the 9th International AIDS Society Conference on HIV Science in Paris.

To read the full article, click here.

Share on FacebookTweet about this on TwitterShare on Google+Pin on PinterestShare on LinkedIn